Evan Seigerman, BMO, joins ‘Fast Money’ to talk the latest oral obesity treatment data out of Eli Lilly.
Source link
Trending
- China’s SMIC says Trump tariffs did not cause expected ‘hard landing’
- What private assets in retirement plans mean for investors
- Japan says U.S. promises to fix double tariff oversight
- Israel says it will retake Gaza City, escalating war with Hamas
- Satellite images show Israel building up forces for a possible ground invasion of Gaza, sources say
- SoftBank Group shares surge 13% to a record high after quarterly profit beat estimates
- Tariffs have come — but ‘TACO trade’ seems to be still on
- Market believes Intel -Trump turmoil will pass, says Intelligent Alpha CEO
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
